Kestra Advisory Services’s DexCom DXCM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $815K | Sell |
9,339
-492
| -5% | -$42.9K | ﹤0.01% | 1617 |
|
|
2025
Q1 | $671K | Sell |
9,831
-9,885
| -50% | -$675K | ﹤0.01% | 1633 |
|
|
2024
Q4 | $1.53M | Buy |
19,716
+1,304
| +7% | +$101K | 0.01% | 1145 |
|
|
2024
Q3 | $1.23M | Buy |
18,412
+4,126
| +29% | +$277K | 0.01% | 1208 |
|
|
2024
Q2 | $1.62M | Sell |
14,286
-128
| -0.9% | -$14.5K | 0.01% | 1067 |
|
|
2024
Q1 | $2M | Buy |
14,414
+172
| +1% | +$23.9K | 0.01% | 880 |
|
|
2023
Q4 | $1.77M | Buy |
14,242
+407
| +3% | +$50.5K | 0.01% | 849 |
|
|
2023
Q3 | $1.29M | Sell |
13,835
-1,785
| -11% | -$167K | 0.01% | 875 |
|
|
2023
Q2 | $2.01M | Buy |
15,620
+1,866
| +14% | +$240K | 0.02% | 670 |
|
|
2023
Q1 | $1.6M | Sell |
13,754
-14,213
| -51% | -$1.65M | 0.02% | 733 |
|
|
2022
Q4 | $3.17M | Buy |
27,967
+4,187
| +18% | +$474K | 0.03% | 573 |
|
|
2022
Q3 | $1.92M | Sell |
23,780
-7,053
| -23% | -$568K | 0.02% | 680 |
|
|
2022
Q2 | $2.3M | Buy |
30,833
+15,177
| +97% | +$1.13M | 0.02% | 623 |
|
|
2022
Q1 | $2M | Buy |
15,656
+6,360
| +68% | +$813K | 0.02% | 675 |
|
|
2021
Q4 | $1.25M | Sell |
9,296
-704
| -7% | -$94.5K | 0.01% | 884 |
|
|
2021
Q3 | $1.37M | Buy |
10,000
+1,492
| +18% | +$204K | 0.01% | 861 |
|
|
2021
Q2 | $908K | Buy |
8,508
+1,284
| +18% | +$137K | 0.01% | 996 |
|
|
2021
Q1 | $649K | Buy |
7,224
+568
| +9% | +$51K | 0.01% | 1070 |
|
|
2020
Q4 | $604K | Buy |
6,656
+6,436
| +2,925% | +$584K | 0.01% | 1110 |
|
|
2020
Q3 | $1.46M | Buy |
+220
| New | +$1.46M | 0.03% | 508 |
|